Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients

[1]  D. Valeyre,et al.  Increase in both angiogenic and angiostatic mediators in patients with idiopathic pulmonary fibrosis. , 2014, Pathologie-biologie.

[2]  M. Myllärniemi,et al.  Transforming Growth Factor Beta 1 Activation, Storage, and Signaling Pathways in Idiopathic Pulmonary Fibrosis in Dogs , 2014, Journal of veterinary internal medicine.

[3]  Ying Shi,et al.  Transforming Growth Factor-β1 Downregulates Vascular Endothelial Growth Factor-D Expression in Human Lung Fibroblasts via the Jun NH2-Terminal Kinase Signaling Pathway , 2014, Molecular medicine.

[4]  T. Sugai,et al.  Heterogeneous characteristics of lymphatic microvasculatures associated with pulmonary sarcoid granulomas. , 2013, Annals of the American Thoracic Society.

[5]  A. Karameris,et al.  Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients , 2012, BMC Research Notes.

[6]  A. Grobbelaar,et al.  The role of the TGF-β family in wound healing, burns and scarring: a review. , 2012, International journal of burns and trauma.

[7]  W. Piotrowski.  Prognostic Factors in Sarcoidosis , 2011 .

[8]  A. Fal,et al.  [Recommendation of the Polish Respiratory Society for bronchoalveolar lavage (BAL) sampling, processing and analysis methods]. , 2011, Pneumonologia i alergologia polska.

[9]  G. Nickenig,et al.  Transforming growth factor-&bgr; gene polymorphisms in different phenotypes of sarcoidosis , 2010, European Respiratory Journal.

[10]  U. Demkow,et al.  Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function , 2010, European journal of medical research.

[11]  D. Spandidos,et al.  Different Activity of the Biological Axis VEGF-Flt-1 (fms-Like Tyrosine Kinase 1) and CXC Chemokines between Pulmonary Sarcoidosis and Idiopathic Pulmonary Fibrosis: A Bronchoalveolar Lavage Study , 2010, Clinical & developmental immunology.

[12]  L. Farkas,et al.  VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. , 2009, The Journal of clinical investigation.

[13]  I. Stříž,et al.  Bronchoalveolar Lavage Fluid Cellular Characteristics, Functional Parameters and Cytokine and Chemokine Levels in Interstitial Lung Diseases , 2009, Scandinavian journal of immunology.

[14]  E. Fireman,et al.  Angiogenic cytokines in induced sputum of patients with sarcoidosis , 2009, Respirology.

[15]  P. Wolters,et al.  Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. , 2008, The Journal of clinical investigation.

[16]  J. Grunewald,et al.  Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis , 2008, Clinical and experimental immunology.

[17]  K. Welsh,et al.  TGF-β1 Variants in Chronic Beryllium Disease and Sarcoidosis1 , 2007, The Journal of Immunology.

[18]  H. Moses,et al.  A tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF‐β signaling , 2007, Journal of cellular biochemistry.

[19]  R. Weiskirchen,et al.  Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. , 2006, Chest.

[20]  P. Debré,et al.  The immune paradox of sarcoidosis and regulatory T cells , 2006, The Journal of experimental medicine.

[21]  K. Yamauchi,et al.  Vascular Endothelial Cell Growth Factor Attenuates Actions of Transforming Growth Factor-β in Human Endothelial Cells* , 2004, Journal of Biological Chemistry.

[22]  Redakcja PiAP.  ZALECENIA POLSKIEGO TOWARZYSTWA FTYZJOPNEUMONOLOGICZNEGO DOTYCZĄCE WYKONYWANIA BADAŃ SPIROMETRYCZNYCH , 2004 .

[23]  J. Vries,et al.  Sarcoidosis: assessment of disease severity using HRCT , 2003, European Radiology.

[24]  H. Magnussen,et al.  Noninvasive monitoring of airway inflammation. , 2000, The European respiratory journal.

[25]  D. Ziora,et al.  [Proangiogenic cytokines (bFGF and VEGF) in BALF from two different lung segments examined by high resolution computed tomography (HRCT) in patients with sarcoidosis]. , 2000, Pneumonologia i alergologia polska.

[26]  M. Copin,et al.  Transforming growth factor-β 1 in sarcoidosis , 1998 .

[27]  L. Newman,et al.  Medical progress : Sarcoidosis , 1997 .

[28]  K. Flanders,et al.  TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. , 1996, American journal of respiratory cell and molecular biology.

[29]  M. Spiteri,et al.  Pulmonary sarcoidosis: patterns of cytokine release in vitro. , 1996, The European respiratory journal.

[30]  Standardized lung function testing. Official statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.